Skip to main content
Erschienen in: PharmacoEconomics 12/2012

01.12.2012 | Original Research Article

What’s Good and Bad About Contraceptive Products?

A Best-Worst Attribute Experiment Comparing the Values of Women Consumers and GPs

verfasst von: Ms Stephanie A. Knox, Rosalie C. Viney, Deborah J. Street, Marion R. Haas, Denzil G. Fiebig, Edith Weisberg, Deborah Bateson

Erschienen in: PharmacoEconomics | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

In the past decade, the range of contraceptives available has increased dramatically. There are limited data on the factors that determine women’s choices on contraceptive alternatives or what factors providers consider most important when recommending contraceptive products to women.

Objectives

Our objectives were to compare women’s (consumers’) preferences and GPs’ (providers’) views in relation to existing and new contraceptive methods, and particularly to examine what factors increase the acceptability of different contraceptive products.

Methods

A best-worst attribute stated-choice experiment was completed online. Participants (Australian women of reproductive age and Australian GPs) completed questions on 16 contraceptive profiles. 200 women of reproductive age were recruited through a commercial panel. GPs from all states of Australia were randomly sampled and approached by phone; 162 GPs agreed to participate. Participants chose the best and worst attribute levels of hypothetical but realistic prescribed contraceptive products. Best and worst choices were modelled using multinomial logit and product features were ranked from best to worst according to the size of model coefficients.

Results

The most attractive feature of the contraceptive products for both GPs and women consumers were an administration frequency of longer than 1 year and light or no bleeding. Women indicated that the hormonal vaginal ring was the least attractive mode of administration.

Conclusions

Women and GPs agree that longer-acting methods with less bleeding are important features in preferred methods of contraception; however, women are also attracted to products involving less invasive modes of administration. While the vaginal ring may fill the niche in Australia for a relatively non-invasive, moderately long-acting and effective contraceptive, the results of this study indicate that GPs will need to promote the benefits of the vaginal ring to overcome negative perceptions about this method among women who may benefit from using it.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Yusuf F, Siedlecky S. Patterns of contraceptive use in Australia: analysis of the 2001 national health survey. J Biosoc Sci 2007; 39(5): 735–44CrossRef Yusuf F, Siedlecky S. Patterns of contraceptive use in Australia: analysis of the 2001 national health survey. J Biosoc Sci 2007; 39(5): 735–44CrossRef
2.
Zurück zum Zitat Gray E, McDonald P. Using a reproductive life course approach to understand contraceptive method use in Australia. J Biosoc Sci 2010; 42(1): 43–57CrossRef Gray E, McDonald P. Using a reproductive life course approach to understand contraceptive method use in Australia. J Biosoc Sci 2010; 42(1): 43–57CrossRef
3.
Zurück zum Zitat Novák A, de la Loge C, Abetz L, et al. The combined contraceptive vaginal ring, Nuvaring: an international study of user acceptability. Contraception 2002; 67: 187–94CrossRef Novák A, de la Loge C, Abetz L, et al. The combined contraceptive vaginal ring, Nuvaring: an international study of user acceptability. Contraception 2002; 67: 187–94CrossRef
4.
Zurück zum Zitat Fiebig DG, Knox S, Viney R, et al. Preferences for new and existing contraceptive products. Health Econ 2011; 20: 35–52CrossRef Fiebig DG, Knox S, Viney R, et al. Preferences for new and existing contraceptive products. Health Econ 2011; 20: 35–52CrossRef
5.
Zurück zum Zitat Flynn TN, Louviere JJ, Peters TJ, et al. Best-worst scaling: what it can do for health care research and how to do it. J Health Econ 2007; 26(1): 171–89CrossRef Flynn TN, Louviere JJ, Peters TJ, et al. Best-worst scaling: what it can do for health care research and how to do it. J Health Econ 2007; 26(1): 171–89CrossRef
6.
Zurück zum Zitat Louviere JJ, Islam T. A comparison of importance weights and willingness-to-pay measures derived from choice-based conjoint, constant sum scales and best-worst scaling. J Bus Res 2008; 61: 903–11CrossRef Louviere JJ, Islam T. A comparison of importance weights and willingness-to-pay measures derived from choice-based conjoint, constant sum scales and best-worst scaling. J Bus Res 2008; 61: 903–11CrossRef
7.
Zurück zum Zitat Marley AAJ, Louviere JJ. Some probabilistic models of best, worst, and best-worst choices. J Math Psychol 2005; 49: 464–80CrossRef Marley AAJ, Louviere JJ. Some probabilistic models of best, worst, and best-worst choices. J Math Psychol 2005; 49: 464–80CrossRef
8.
Zurück zum Zitat Marley AAJ, Flynn TN, Louviere JJ. Probabilistic models of set-dependent and attribute level best-worst choices. J Math Psychol 2008; 52: 281–96CrossRef Marley AAJ, Flynn TN, Louviere JJ. Probabilistic models of set-dependent and attribute level best-worst choices. J Math Psychol 2008; 52: 281–96CrossRef
9.
Zurück zum Zitat Hall J, Fiebig DG, King MT, et al. What influences participation in genetic carrier testing? Results from a discrete choice experiment. J Health Econ 2006; 25(3): 520–37CrossRef Hall J, Fiebig DG, King MT, et al. What influences participation in genetic carrier testing? Results from a discrete choice experiment. J Health Econ 2006; 25(3): 520–37CrossRef
10.
Zurück zum Zitat Lancsar E, Louviere J, Flynn T. Several methods to investigate relative attribute impact in stated preference experiments. Soc Sci Med 2007; 64(8): 1738–53CrossRef Lancsar E, Louviere J, Flynn T. Several methods to investigate relative attribute impact in stated preference experiments. Soc Sci Med 2007; 64(8): 1738–53CrossRef
11.
Zurück zum Zitat Fiebig DG, Haas M, Hossain I, et al. Decisions about Pap tests: what influences women and providers? Soc Sci Med 2009; 68(10): 1766–74CrossRef Fiebig DG, Haas M, Hossain I, et al. Decisions about Pap tests: what influences women and providers? Soc Sci Med 2009; 68(10): 1766–74CrossRef
12.
Zurück zum Zitat Coast J, Salisbury C, de Berker D, et al. Preferences for aspects of a dermatology consultation. Br J Dermatol 2006; 155(2): 387–92CrossRef Coast J, Salisbury C, de Berker D, et al. Preferences for aspects of a dermatology consultation. Br J Dermatol 2006; 155(2): 387–92CrossRef
13.
Zurück zum Zitat Coast J, Flynn TN, Natarajan L, et al. Valuing the ICECAP capability index for older people. Soc Sci Med 2008; 67(5): 874–82CrossRef Coast J, Flynn TN, Natarajan L, et al. Valuing the ICECAP capability index for older people. Soc Sci Med 2008; 67(5): 874–82CrossRef
14.
Zurück zum Zitat Finn A, Louviere JJ. Determining the appropriate response to evidence of public concern: the case of food safety. J Public Policy Mark 1992; 11(2): 12–25CrossRef Finn A, Louviere JJ. Determining the appropriate response to evidence of public concern: the case of food safety. J Public Policy Mark 1992; 11(2): 12–25CrossRef
15.
Zurück zum Zitat Street DJ, Burgess L. The construction of optimal stated choice experiments: theory and methods. Hoboken (NJ): Wiley, 2007CrossRef Street DJ, Burgess L. The construction of optimal stated choice experiments: theory and methods. Hoboken (NJ): Wiley, 2007CrossRef
17.
Zurück zum Zitat Britt H, Miller GC, Charles J, et al. General practice activity in Australia 2007–2008. Canberra: Australian Institute of Health and Welfare, 2008 Britt H, Miller GC, Charles J, et al. General practice activity in Australia 2007–2008. Canberra: Australian Institute of Health and Welfare, 2008
18.
Zurück zum Zitat Australian Bureau of Statistics. Australian historical population statistics. Canberra (ACT): ABS, 2006 Australian Bureau of Statistics. Australian historical population statistics. Canberra (ACT): ABS, 2006
19.
Zurück zum Zitat Gilliam M, Holmquist S, Berlin A. Factors associated with willingness to use the contraceptive vaginal ring. Contraception 2007; 76: 30–4CrossRef Gilliam M, Holmquist S, Berlin A. Factors associated with willingness to use the contraceptive vaginal ring. Contraception 2007; 76: 30–4CrossRef
20.
Zurück zum Zitat Creinin MD, Meyn LA, Borgatta L, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol 2008; 111 (2 Pt 1): 267–77CrossRef Creinin MD, Meyn LA, Borgatta L, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol 2008; 111 (2 Pt 1): 267–77CrossRef
21.
Zurück zum Zitat de Bekker-Grob EW, Essink-Bot ML, Meerding WJ, et al. Preferences of GPs and patients for preventive osteoporosis drug treatment: a discrete-choice experiment. Pharmacoeconomics 2009; 27(3): 211–9CrossRef de Bekker-Grob EW, Essink-Bot ML, Meerding WJ, et al. Preferences of GPs and patients for preventive osteoporosis drug treatment: a discrete-choice experiment. Pharmacoeconomics 2009; 27(3): 211–9CrossRef
22.
Zurück zum Zitat Ratcliffe J, Couzner L, Flynn T, et al. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods. Appl Health Econ Health Policy 2011; 9(1): 15–27CrossRef Ratcliffe J, Couzner L, Flynn T, et al. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods. Appl Health Econ Health Policy 2011; 9(1): 15–27CrossRef
23.
Zurück zum Zitat Potoglou D, Burge P, Flynn T, et al. Best-worst scaling vs. discrete choice experiments: an empirical comparison using social care data. Soc Sci Med 2011; 72(10): 1717–27CrossRef Potoglou D, Burge P, Flynn T, et al. Best-worst scaling vs. discrete choice experiments: an empirical comparison using social care data. Soc Sci Med 2011; 72(10): 1717–27CrossRef
Metadaten
Titel
What’s Good and Bad About Contraceptive Products?
A Best-Worst Attribute Experiment Comparing the Values of Women Consumers and GPs
verfasst von
Ms Stephanie A. Knox
Rosalie C. Viney
Deborah J. Street
Marion R. Haas
Denzil G. Fiebig
Edith Weisberg
Deborah Bateson
Publikationsdatum
01.12.2012
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 12/2012
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/11598040-000000000-00000

Weitere Artikel der Ausgabe 12/2012

PharmacoEconomics 12/2012 Zur Ausgabe

Acknowledgments

Acknowledgement